Free Account Opening + AMC Free Demat
Loading...

Parabolic Drugs IPO vs SJVN IPO

Comparision between Parabolic Drugs IPO and SJVN IPO.

IPO Details

Parabolic Drugs IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while SJVN IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

  Parabolic Drugs IPO SJVN IPO
Logo Parabolic Drugs IPO Logo SJVN IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Book Built Issue
Listing At BSE, NSE BSE, NSE
Lead Managers ICICI Securities Limited

Spa Capital Advisors Ltd
Idbi Capital Market Services Limited

Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd)

Jm Financial Limited

SBI Capital Markets Limited
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Parabolic Drugs IPO is up to ₹200.00 Cr whereas the issue size of the SJVN IPO is up to ₹1,062.74 Cr. The final issue price of Parabolic Drugs IPO is ₹75.00 per share and of SJVN IPO is ₹26.00 per share.

  Parabolic Drugs IPO SJVN IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹75.00 per share ₹23.00 per share
Issue Price (Upper) ₹85.00 per share ₹26.00 per share
Issue Price (Final) ₹75.00 per share ₹26.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 80 shares 250 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 2,66,66,667 shares 41,50,00,000 shares
Issue Size Total (Amount) up to ₹200.00 Cr up to ₹1,062.74 Cr

IPO Timetable

Parabolic Drugs IPO opens on Jun 14, 2010, while SJVN IPO opens on Apr 29, 2010. The closing date of Parabolic Drugs IPO and SJVN IPO is Jun 17, 2010, and May 03, 2010, respectively.

  Parabolic Drugs IPO SJVN IPO
Anchor Bid Date
Issue Open Jun 14, 2010 Apr 29, 2010
Issue Close Jun 17, 2010 May 03, 2010
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Parabolic Drugs IPO P/E ratio is , as compared to SJVN IPO P/E ratio of .

  Parabolic Drugs IPO SJVN IPO
Financial
ParticularsFor the year/period ended (Rs. in Crore)
30-Sept-0931-Mar-0931-Mar-0831-Mar-0731-Mar-0631-Mar-05
Total Income233.43396.94273.94150.5690.1250.90
Profit After Tax (PAT)12.4121.0929.6713.588.223.27
ParticularsFor the year/period ended (Rs. in Million)
30-Sep-0931-Mar-0931-Mar-0831-Mar-0731-Mar-06
Total Income11,347.316,348.414,622.814,761.713,509.4
Profit After Tax (PAT)6,186.27,594.47,169.46,499.85,854.3
Promoter Shareholding (Pre-Issue) 63.2% 20%
Promoter Shareholding (Post-Issue) 46.5% 20%
P/E Ratio
Market Cap
ROE
ROCE 6.21%%
Debt/Equity
EPS
RoNW 19.96%% 12.5%%

Shares Offered

In the Parabolic Drugs IPO retail investors (RII) are offered 91,58,334 shares while in SJVN IPO retail investors are offered 91,58,334 shares. Qualified institutional buyers (QIB) are offered 1,30,83,333 shares in Parabolic Drugs IPO and 24,69,90,000 shares in SJVN IPO.

  Parabolic Drugs IPO SJVN IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 1,30,83,333 shares 24,69,90,000 shares
NII 39,25,000 shares 4,11,65,000 shares
RII 91,58,334 shares 12,34,95,000 shares
Employee 5,00,000 shares 33,50,000 shares
Others
Total 2,66,66,667 shares 41,50,00,000 shares

Bids Received (Subscription)

Parabolic Drugs IPO subscribed 1.04x in total, whereas SJVN IPO subscribed 6.64x.

  Parabolic Drugs IPO SJVN IPO
QIB (times) 1.48x 9.03x
NII (times) 1.20x 3.39x
Big NII (times)
Small NII (times)
RII (times) 0.40x 3.12x
Employee (times) 0.11x 0.25x
Other (times)
Total (times) 1.04x 6.64x

Comments

Add a public comment...